Literature DB >> 8833497

Amiodarone in a newborn with ventricular tachycardia and an intracardiac tumor: adjusting the dose according to an individualized dosing regimen.

T Bouillon1, H Schiffmann, D Bartmus, U Gundert-Remy.   

Abstract

We report the successful management of recurrent ventricular tachycardias in a newborn suffering from an intracardiac tumor. Amiodarone was the only agent able to control the tachycardias and did so as long as an individually titrated plasma concentration above 0.8 mu mol/L was maintained. Because no therapeutic plasma concentration has been defined in children and no kinetic studies are available in this population, we optimized the dosing regimen based on a computer simulation, taking into account the pharmacokinetic parameters of the patient and the individual concentration-effect relation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8833497     DOI: 10.1007/BF02505094

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  11 in total

1.  Newer antiarrhythmic drugs in children.

Authors:  J P Moak; R T Smith; A Garson
Journal:  Am Heart J       Date:  1987-01       Impact factor: 4.749

2.  Long-term follow-up of amiodarone therapy in the young: continued efficacy, unimpaired growth, moderate side effects.

Authors:  P Guccione; T Paul; A Garson
Journal:  J Am Coll Cardiol       Date:  1990-04       Impact factor: 24.094

Review 3.  Amiodarone therapeutic plasma concentration monitoring. Is it practical?

Authors:  T Maling
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

4.  Efficacy and safety of amiodarone in infants.

Authors:  C O Shuler; C L Case; P C Gillette
Journal:  Am Heart J       Date:  1993-05       Impact factor: 4.749

5.  Efficacy and safety of long-term amiodarone in treatment of cardiac arrhythmias: dosage experience.

Authors:  C I Haffajee; J C Love; J S Alpert; G K Asdourian; K C Sloan
Journal:  Am Heart J       Date:  1983-10       Impact factor: 4.749

6.  Pharmacokinetics of amiodarone after intravenous and oral administration.

Authors:  F Andreasen; H Agerbaek; P Bjerregaard; H Gøtzsche
Journal:  Eur J Clin Pharmacol       Date:  1981-03       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics of amiodarone.

Authors:  R Latini; G Tognoni; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

8.  Amiodarone kinetics after oral doses.

Authors:  R Kannan; K Nademanee; J A Hendrickson; H J Rostami; B N Singh
Journal:  Clin Pharmacol Ther       Date:  1982-04       Impact factor: 6.875

9.  Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases.

Authors:  P Coumel; J Fidelle
Journal:  Am Heart J       Date:  1980-12       Impact factor: 4.749

10.  Intravenous and oral amiodarone for arrhythmias in children.

Authors:  C A Bucknall; B R Keeton; P V Curry; M J Tynan; G R Sutherland; D W Holt
Journal:  Br Heart J       Date:  1986-09
View more
  3 in total

1.  Acute hemodynamic effects of intravenous amiodarone treatment in paediatric cardiac surgical patients.

Authors:  Nikolaus A Haas; Christoph K Camphausen
Journal:  Clin Res Cardiol       Date:  2008-06-05       Impact factor: 5.460

2.  Ventricular tachycardia in a neonate with prenatally diagnosed cardiac tumors: a case with tuberous sclerosis.

Authors:  Y Hirakubo; K Ichihashi; H Shiraishi; M Y Momoi
Journal:  Pediatr Cardiol       Date:  2005 Sep-Oct       Impact factor: 1.838

3.  Congenital giant cardiac tumor with severe left-ventricular inflow and outflow obstruction and arrhythmia treated with pulmonary artery banding and long-term amiodarone infusion.

Authors:  Daiji Takeuchi; Takeshi Hiramatsu; Toshio Nakanishi
Journal:  Ann Pediatr Cardiol       Date:  2012-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.